The International Chronic Myeloid Leukemia Foundation (iCMLf) has awarded the prestigious Rowley Prize to Michael Deininger, MD, PhD, with a formal presentation of the prize taking place earlier in September.
The Utah Center for Bleeding & Clotting Disorders (UCBCD) is committed to providing a comprehensive medical home with state-of-the-art treatment, family-centered education and ground-breaking research to children, adolescents, and adults...
Researchers at Huntsman Cancer Institute at the University of Utah discovered in laboratory studies that an experimental drug called selinexor may block a crucial survival pathway exploited by myelofibrosis cells.
We are pleased to announce a request for postdoctoral applications on the T32 Hematology Training Grant. The application deadline is July 15, 2019. The application details are enclosed. Please contact...
The 2019 Hematology and Metals in Medicine Symposium will be held on Friday June 14, 2019. Breakfast, lunch, and coffee breaks will be provided. HSEB 4100B 8:30 AM - 4:15...
The Hematology Research Symposium on June7-8, 2019 will feature a host of internal and external experts promoting the many strengths of hematologic research including lymphoid and myeloid malignancies, immunotherapy, genomics...
Since 2015, the multidisciplinary Utah Amyloidosis Program has focused on improving care for patients with amyloidosis—a rare but serious protein deposition condition affecting multiple body systems.
Dr. Deininger, professor and chief of the Division of Hematology and Hematologic Malignancies, was chosen as the recipient of the prestigious 2019 Rowley Prize awarded by the International Chronic Myeloid...
